Advertisement

Complications Associated With Ureteroscopic Management of Upper Tract Urothelial Carcinoma

Published:October 05, 2020DOI:https://doi.org/10.1016/j.urology.2020.09.036

      Abstract

      Objectives

      To compile and examine safety data from clinical studies of endoscopic management of patients with low-grade upper tract urothelial carcinoma (UTUC) to identify rates and factors associated with reported complications.

      Methods

      Ovid Medline and Ovid Medline Daily (with Embase as secondary search) including citations from 1946-2018 were queried using the following terms: ureteroscopy, ureter, catheter, endoscopy, complication, adverse events, morbidity, ablation, laser, upper tract urothelial carcinoma, ureteral stricture, ureteral stenosis, and ureteral injury. Abstracts were reviewed for relevance; diagnostic studies, case studies, and reviews were excluded.

      Results

      Thirty-eight publications (7 prospective, 31 retrospective) representing >1100 patients were identified. Ureteral stricture was the most frequently reported complication (studies; rates) (26/38; 0-27%), with incidence associated with number of procedures and treatment method. Bleeding, infection, and fever were most common with adjuvant treatment (BCG or mitomycin). Serious and fatal complications were rare.

      Conclusions

      Ureteral stricture is the most frequent complication of endoscopic UTUC management but can be managed successfully in most cases. Most complications were minor. Although additional prospective studies are needed, these results support the safety of ureteroscopic management of UTUC in appropriately selected patients.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Urology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Roupret M
        • Babjuk M
        • Comperat E
        • et al.
        European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2017 Update.
        Eur Urol. 2018; 73: 111-122
        • Margulis V
        • Shariat SF
        • Matin SF
        • et al.
        Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration.
        Cancer. 2009; 115: 1224-1233
        • Cutress ML
        • Stewart GD
        • Zakikhani P
        • Phipps S
        • Thomas BG
        • Tolley DA
        Ureteroscopic and percutaneous management of upper tract urothelial carcinoma (UTUC): systematic review.
        BJU Int. 2012; 110: 614-628
        • Browne BM
        • Stensland KD
        • Moynihan MJ
        • Canes D
        An analysis of staging and treatment trends for upper tract urothelial carcinoma in the National Cancer Database.
        Clin Genitourin Cancer. 2018; 16: e743-e750
        • Abboudi H
        • Ahmed K
        • Royle J
        • Khan MS
        • Dasgupta P
        • N'Dow J
        Ureteric injury: a challenging condition to diagnose and manage.
        Nat Rev Urol. 2013; 10: 108-115
        • Drake T
        • Grivas N
        • Dabestani S
        • et al.
        What are the benefits and harms of ureteroscopy compared with shock-wave lithotripsy in the treatment of upper ureteral stones? A systematic review.
        Eur Urol. 2017; 72: 772-786
        • Abdel-Razzak OM
        • Bagley DH.
        Clinical experience with flexible ureteropyeloscopy.
        J Urol. 1992; 148: 1788-1792
        • Andersen JR
        • Kristensen JK.
        Ureteroscopic management of transitional cell tumors.
        Scand J Urol Nephrol. 1994; 28: 153-157
        • Cornu JN
        • Roupret M
        • Carpentier X
        • et al.
        Oncologic control obtained after exclusive flexible ureteroscopic management of upper urinary tract urothelial cell carcinoma.
        World J Urol. 2010; 28: 151-156
        • Gaboardi F
        • Bozzola A
        • Dotti E
        • Galli L
        Conservative treatment of upper urinary tract tumors with Nd:YAG laser.
        J Endourol. 1994; 8: 37-41
        • Grasso M
        • Fraiman M
        • Levine M
        Ureteropyeloscopic diagnosis and treatment of upper urinary tract urothelial malignancies.
        Urology. 1999; 54: 240-246
        • Hubosky SG
        • Boman BM
        • Charles S
        • Bibbo M
        • Bagley DH
        Ureteroscopic management of upper tract urothelial carcinoma (UTUC) in patients with Lynch Syndrome (hereditary nonpolyposis colorectal cancer syndrome).
        BJU Int. 2013; 112: 813-819
        • Johnson GB
        • Fraiman M
        • Grasso M
        Broadening experience with the retrograde endoscopic management of upper urinary tract urothelial malignancies.
        BJU Int. 2005; 95: 110-113
        • Iborra I
        • Solsona E
        • Casanova J
        • Ricos JV
        • Rubio J
        • Climent MA
        Conservative elective treatment of upper urinary tract tumors: a multivariate analysis of prognostic factors for recurrence and progression.
        J Urol. 2003; 169: 82-85
        • Kalaitzis C
        • Zisimopoulos A
        • Giannakopoulos S
        • Touloupidis S
        Ureteroscopic laser treatment of upper urinary tract urothelial cell carcinomas: can a tumour free status be achieved.
        Adv Urol. 2013; 2013429585
        • Clark PE
        • Streem SB
        • Geisinger MA
        13-year experience with percutaneous management of upper tract transitional cell carcinoma.
        J Urol. 1999; 161 (discussion 775-776): 772-775
        • Cutress ML
        • Stewart GD
        • Wells-Cole S
        • Phipps S
        • Thomas BG
        • Tolley DA
        Long-term endoscopic management of upper tract urothelial carcinoma: 20-year single-centre experience.
        BJU Int. 2012; 110: 1608-1617
        • Daneshmand S
        • Quek ML
        • Huffman JL
        Endoscopic management of upper urinary tract transitional cell carcinoma: long-term experience.
        Cancer. 2003; 98: 55-60
        • Deligne E
        • Colombel M
        • Badet L
        • et al.
        Conservative management of upper urinary tract tumors.
        Eur Urol. 2002; 42: 43-48
        • Elliott DS
        • Segura JW
        • Lightner D
        • Patterson DE
        • Blute ML
        Is nephroureterectomy necessary in all cases of upper tract transitional cell carcinoma? Long-term results of conservative endourologic management of upper tract transitional cell carcinoma in individuals with a normal contralateral kidney.
        Urology. 2001; 58: 174-178
        • Engelmyer EI
        • Belis JA.
        Long-term ureteroscopic management of low-grade transitional cell carcinoma of the upper urinary tract.
        Tech Urol. 1996; 2: 113-116
        • Gadzinski AJ
        • Roberts WW
        • Faerber GJ
        • Wolf Jr., JS
        Long-term outcomes of nephroureterectomy versus endoscopic management for upper tract urothelial carcinoma.
        J Urol. 2010; 183: 2148-2153
        • Keeley Jr., FX
        • Bibbo M
        • Bagley DH
        Ureteroscopic treatment and surveillance of upper urinary tract transitional cell carcinoma.
        J Urol. 1997; 157: 1560-1565
        • Krambeck AE
        • Murat FJ
        • Gettman MT
        • Chow GK
        • Patterson DE
        • Segura JW
        The evolution of ureteroscopy: a modern single-institution series.
        Mayo Clinic proceedings. 2006; 81: 468-473
        • Krambeck AE
        • Thompson RH
        • Lohse CM
        • Patterson DE
        • Elliott DS
        • Blute ML
        Imperative indications for conservative management of upper tract transitional cell carcinoma.
        J Urol. 2007; 178 (discussion 796-797): 792-796
        • Krambeck AE
        • Thompson RH
        • Lohse CM
        • et al.
        Endoscopic management of upper tract urothelial carcinoma in patients with a history of bladder urothelial carcinoma.
        J Urol. 2007; 177: 1721-1726
        • Martinez-Pineiro JA
        • Garcia Matres MJ
        • Martinez-Pineiro L
        Endourological treatment of upper tract urothelial carcinomas: analysis of a series of 59 tumors.
        J Urol. 1996; 156: 377-385
        • Matsuoka K
        • Lida S
        • Tomiyasu K
        • Inoue M
        • Noda S
        Transurethral endoscopic treatment of upper urinary tract tumors using a holmium:YAG laser.
        Lasers Surg Med. 2003; 32: 336-340
        • Metcalfe M
        • Wagenheim G
        • Xiao L
        • et al.
        Induction and maintenance adjuvant mitomycin C topical therapy for upper tract urothelial carcinoma: tolerability and intermediate term outcomes.
        J Endourol. 2017; 31: 946-953
        • Reisiger K
        • Hruby G
        • Clayman RV
        • Landman J
        Office-based surveillance ureteroscopy after endoscopic treatment of transitional cell carcinoma: technique and clinical outcome.
        Urology. 2007; 70: 263-266
        • Roupret M
        • Hupertan V
        • Traxer O
        • et al.
        Comparison of open nephroureterectomy and ureteroscopic and percutaneous management of upper urinary tract transitional cell carcinoma.
        Urology. 2006; 67: 1181-1187
        • Schmeller NT
        • Hofstetter AG.
        Laser treatment of ureteral tumors.
        J Urol. 1989; 141: 840-843
        • Sowter SJ
        • Ilie CP
        • Efthimiou I
        • Tolley DA
        Endourologic management of patients with upper-tract transitional-cell carcinoma: long-term follow-up in a single center.
        J Endourol. 2007; 21: 1005-1009
        • Su X
        • Fang D
        • Zhang L
        • et al.
        Treatment strategies for upper tract urothelial carcinoma (UTUC) of a solitary kidney: a single-institutional analysis of 61 cases.
        Int Urol Nephrol. 2016; 48: 1601-1608
        • Suh RS
        • Faerber GJ
        • Wolf Jr., JS
        Predictive factors for applicability and success with endoscopic treatment of upper tract urothelial carcinoma.
        J Urol. 2003; 170: 2209-2216
        • Wen J
        • Ji ZG
        • Li HZ
        Treatment of upper tract urothelial carcinoma with ureteroscopy and thulium laser: a retrospective single center study.
        BMC Cancer. 2018; 18: 196
        • Aboumarzouk OM
        • Somani B
        • Ahmad S
        • Nabi G
        • Townell N
        • Kata SG
        Mitomycin C instillation following ureterorenoscopic laser ablation of upper urinary tract carcinoma.
        Urol Ann. 2013; 5: 184-189
        • Hayashida Y
        • Nomata K
        • Noguchi M
        • et al.
        Long-term effects of bacille Calmette-Guerin perfusion therapy for treatment of transitional cell carcinoma in situ of upper urinary tract.
        Urology. 2004; 63: 1084-1088
        • Keeley Jr., FX
        • Bagley DH.
        Adjuvant mitomycin C following endoscopic treatment of upper tract transitional cell carcinoma.
        J Urol. 1997; 158: 2074-2077
        • Miyake H
        • Eto H
        • Hara S
        • Okada H
        • Kamidono S
        • Hara I
        Clinical outcome of bacillus Calmette-Guerin perfusion therapy for carcinoma in situ of the upper urinary tract.
        Int J Urol. 2002; 9: 677-680
        • Okubo K
        • Ichioka K
        • Terada N
        • Matsuta Y
        • Yoshimura K
        • Arai Y
        Intrarenal bacillus Calmette-Guerin therapy for carcinoma in situ of the upper urinary tract: long-term follow-up and natural course in cases of failure.
        BJU Int. 2001; 88: 343-347
        • Painter DJ
        • Denton K
        • Timoney AG
        • Keeley FX
        Ureteroscopic management of upper-tract urothelial cancer: an exciting nephron-sparing option or an unacceptable risk?.
        J Endourol. 2008; 22: 1237-1239
        • Patel A
        • Fuchs GJ.
        New techniques for the administration of topical adjuvant therapy after endoscopic ablation of upper urinary tract transitional cell carcinoma.
        J Urol. 1998; 159: 71-75
        • Sharpe JR
        • Duffy G
        • Chin JL
        Intrarenal bacillus Calmette-Guerin therapy for upper urinary tract carcinoma in situ.
        J Urol. 1993; 149 (discussion 459-460): 457-459
        • Soderdahl DW
        • Fabrizio MD
        • Rahman NU
        • Jarrett TW
        • Bagley DH
        Endoscopic treatment of upper tract transitional cell carcinoma.
        Urol Oncol. 2005; 23: 114-122
        • Seisen T
        • Peyronnet B
        • Dominguez-Escrig JL
        • et al.
        Oncologic outcomes of kidney-sparing surgery versus radical nephroureterectomy for upper tract urothelial carcinoma: a systematic review by the EAU non-muscle invasive bladder cancer guidelines panel.
        Eur Urol. 2016; 70: 1052-1068
        • Yakoubi R
        • Colin P
        • Seisen T
        • et al.
        Radical nephroureterectomy versus endoscopic procedures for the treatment of localised upper tract urothelial carcinoma: a meta-analysis and a systematic review of current evidence from comparative studies.
        Eur J Surg Oncol. 2014; 40: 1629-1634
        • Moore K
        • Khastgir J
        • Ghei M
        Endoscopic management of upper tract urothelial carcinoma.
        Adv Urol. 2009; 2009620604
        • Lamm DL
        • Blumenstein BA
        • Crawford ED
        • et al.
        A randomized trial of intravesical doxorubicin and immunotherapy with bacille Calmette-Guerin for transitional-cell carcinoma of the bladder.
        N Engl J Med. 1991; 325: 1205-1209
        • Hu H
        • Lu Y
        • He D
        • et al.
        Comparison of minimally invasive percutaneous nephrolithotomy and flexible ureteroscopy for the treatment of intermediate proximal ureteral and renal stones in the elderly.
        Urolithiasis. 2016; 44: 427-434